Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
Clinical trial NCT04009668 · COMPLETED
Trial details
- NCT number
- NCT04009668
- Sponsor
- University of Michigan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2023-09-05
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.